Eli Lilly's oral pill, orforglipron, helped maintain weight loss in patients switching from injectable versions of GLP-1 ...

I used to spend about 60% of each day thinking about food—when was the next meal? What was I going to eat? Would it be ...

Eli Lilly also said it has filed for Food and Drug Administration approval of the daily GLP-1 pill, called orforglipron, for ...

Tirzepatide starts working quickly. You might notice less hunger in a few days or weeks. Average weight loss in 3 weeks is ...

Research suggests certain medications could help build or maintain muscle during weight loss. Here's how they work & how to ...

Eli Lilly and Novo Nordisk — the dominant players in obesity drug development — each submitted a new weight-loss drug to the ...

In the ATTAIN-MAINTAIN study of its orforglipron candidate, switching to the drug after 72 months of injectable treatment ...

Sacramento Telehealth Company Positions Multi-Form Compounded Semaglutide Access Through Licensed Medical Providers Ahead of ...

According to Lilly, a New Drug Application for orforglipron for the treatment of adults with obesity or overweight has been submitted to the Food and Drug Administration.

A growing body of evidence suggests GLP-1 receptor agonists may improve survival as well as reduce chemotherapy-related toxicities in women with breast cancer.

Dec 17 () - Eli Lilly is slashing the prices of its popular ​diabetes and weight-loss drugs Mounjaro ‌and Zepbound by 20% or ...

Clinic Secret is a telehealth platform providing licensed access to GLP-1 weight loss treatments like Ozempic, semaglutide ...